Printed 6/17/2015 Donald McKnight Bushnell, lll Health Research Associates, Inc. 6505 216 th Street SW, Suite 105 Mountlake Terrace, Washington 98043 Tel: (425) 775-6565 Ext. 206 Fax: (425) 775-6734 E-mail: [email protected]Web: http://www.hrainc.net/ Employment History 1998-present Associate Director / Analytic Research. Health Research Associates, Inc., Seattle, WA 1996-1998 Database Manager. Providence Health Plans of Washington, Seattle, WA 1993-1996 Research Consultant. Northwest Prevention Effectiveness Center, University of Washington, School of Public Health and Community Medicine, Seattle, WA 1990-1993 Data Control Technician III. Center for Health Promotion in Older Adults (HPOA), University of Washington, School of Public Health and Community Medicine, Seattle, WA 1989-1990 Systems Analyst. Department of Health Services, University of Washington, School of Public Health and Community Medicine, Seattle, WA 1985-1989 Data Analyst / Research Assistant. Department of Health Services, University of Washington, School of Public Health and Community Medicine, Seattle, WA Education 1989 Masters of Arts, Architecture, University of Washington, Seattle, Washington Publications 2015 Ramasamy A, Martin ML, Blum SI, Liedgens H, Argoff CE, Freynhagen R, Wallace MS, McCarrier KP, BUSHNELL DM, Patrick DL. Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain. Submitted to Journal of Pain 16 June 2015. 2015 Brod M, Blum SI, BUSHNELL DM, Ramasamy A. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure. Quality of Life Research, Accepted 30 May 2015, published online 12 June 2015 [DOI 10.1007/s11136-015-1037-0] 2015 Martin M, Gordon K, Pinto L, BUSHNELL DM, Chau D, Viswanathan HN. The experience of pain and redness in patients with moderate to severe plaque psoriasis. Journal of Dermatological Treatment, Accepted 24 November 2014, published online 30 March 2015 [DOI 10.3109/09546634.2014.996514] 2014 BUSHNELL DM, Martin ML, Scanlon M, Chen T, Chau D, Viswanathan HN. Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory. Quality of Life Research 23(3):897-906, 2014. [Epub 2013 Sep 20]
Transcript
Printed 6/17/2015
Donald McKnight Bushnell, lll Health Research Associates, Inc.
6505 216th Street SW, Suite 105 Mountlake Terrace, Washington 98043 Tel: (425) 775-6565 Ext. 206 Fax: (425) 775-6734 E-mail: [email protected] Web: http://www.hrainc.net/
Employment History 1998-present Associate Director / Analytic Research. Health Research Associates, Inc., Seattle, WA
1996-1998 Database Manager. Providence Health Plans of Washington, Seattle, WA
1993-1996 Research Consultant. Northwest Prevention Effectiveness Center, University of Washington, School of Public Health and Community Medicine, Seattle, WA
1990-1993 Data Control Technician III. Center for Health Promotion in Older Adults (HPOA), University of Washington, School of Public Health and Community Medicine, Seattle, WA
1989-1990 Systems Analyst. Department of Health Services, University of Washington, School of Public Health and Community Medicine, Seattle, WA
1985-1989 Data Analyst / Research Assistant. Department of Health Services, University of Washington, School of Public Health and Community Medicine, Seattle, WA
Education
1989 Masters of Arts, Architecture, University of Washington, Seattle, Washington
Publications
2015 Ramasamy A, Martin ML, Blum SI, Liedgens H, Argoff CE, Freynhagen R, Wallace MS, McCarrier KP, BUSHNELL DM, Patrick DL. Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain. Submitted to Journal of Pain 16 June 2015.
2015 Brod M, Blum SI, BUSHNELL DM, Ramasamy A. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure. Quality of Life Research, Accepted 30 May 2015, published online 12 June 2015 [DOI 10.1007/s11136-015-1037-0]
2015 Martin M, Gordon K, Pinto L, BUSHNELL DM, Chau D, Viswanathan HN. The experience of pain and redness in patients with moderate to severe plaque psoriasis. Journal of Dermatological Treatment, Accepted 24 November 2014, published online 30 March 2015 [DOI 10.3109/09546634.2014.996514]
2014 BUSHNELL DM, Martin ML, Scanlon M, Chen T, Chau D, Viswanathan HN. Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory. Quality of Life Research 23(3):897-906, 2014. [Epub 2013 Sep 20]
Printed 6/17/2015 Publications Continued
Page 2
2013 Brod M, Wolden M, Christensen TL, BUSHNELL DM. A nine country study of the burden of non-severe nocturnal hypoglycemic events on diabetes management and daily function. Diabetes, Obesity and Metabolism 15(6):546-557, 2013.
2013 BUSHNELL DM, Martin ML, McCarrier K, Gordon K, Chiou CF, Huang X, Ortmeier B, Kricorian G. Validation of the Psoriasis Symptom Inventory (PSI), a Patient-Reported Outcome Measure to Assess Psoriasis Symptom Severity. Journal of Dermatological Treatment, 24(5):356-360, 2013.
2012 Peyrot M, BUSHNELL DM, Best JH, Martin ML, Cameron A, Patrick DL. Development and validation of the Self-Management Profile for Type 2 Diabetes (SMP-T2D). Health and Quality of Life Outcomes, 10:125-135, 2012.
2012 Brod M, BUSHNELL DM, Christensen TL. The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes. Journal of Medical Economics 15(5):869-877, 2012.
2012 Brod M, Christensen TL, BUSHNELL DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. Journal of Medical Economics 15(1):1-10, 2012.
2012 Rocha NS, Fleck MP, Power MJ, BUSHNELL DM. Cross-cultural evaluation of the WHOQOL-BREF domains in primary care depressed patients using Rasch analysis. Medical Decision Making 32(1):41-55, 2012.
2012 Rocha NS, Power MJ, BUSHNELL DM, Fleck MP. EUROHIS-QOL 8: Comparative measurement properties to its parent WHOQOL-BREF measure. Value in Health 15:449-457, 2012.
2011 Brod M, Christensen T, Hammer M, Busk AK, BUSHNELL DM. Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures. Quality of Life Research 20(9):1513-1518, 2011.
2011 Brod M, Christensen TL, Thomsen TL, BUSHNELL DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value in Health 14(5):665-671, 2011.
2011 Bennett AV, Patrick DL, BUSHNELL DM, Chiou CF, Diehr P. Comparison of 7-day and repeated 24-h recall of type 2 diabetes. Quality of Life Research 20(5):769-777, 2011.
2010 BUSHNELL DM, Martin ML, Moore KA, Richter HE, Rubin A, Patrick DL. Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Current Medical Research & Opinion 26(12):2745-55, 2010.
2010 Brod M, Valensi P, Shaban JA, BUSHNELL DM, Christensen TL. Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp30) in the IMPROVETM Study – An analysis of the influence of prior and current treatment factors. Quality of Life Research 9:1285-93, 2010.
2010 Brod M, Hammer M, Kragh N, Lessard S, BUSHNELL DM. Development and Validation of the Treatment Related Impact Measure of Weight (TRIM-Weight). Health and Quality of Life Outcomes 8:19, 2010.
Printed 6/17/2015 Publications Continued
Page 3
2009 Brod M, Christensen T, Kongsø JH, BUSHNELL DM. Examining and interpreting responsiveness of the Diabetes Medication Satisfaction Measure (DiabMedSat). Journal of Medical Economics 12(4):309-316, 2009.
2009 Brod M, Hammer M, Christensen T, Lessard S, BUSHNELL DM. Understanding and assessing the impact of treatment in diabetes: The Treatment Related Impact Measure for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device). Health and Quality of Life Outcomes 7:83, 2009.
2009 Martin ML, Patrick DL, BUSHNELL DM, Meltzer EO, Gutierrez B, Parasuraman B. Development of the Asthma Treatment Satisfaction Measure. Current Medical Research & Opinion 25(10):2495-2506, 2009.
2008 Martin ML, Patrick DL, BUSHNELL DM, Gandra SR. Further Validation of an Individualized Migraine Treatment Satisfaction Measure (MTSM). Value in Health 11(5):904-912, 2008.
2007 Huang W, Zhou F, BUSHNELL DM, Diakite C, Yang X. Cultural adaptation and application of the IBS-QOL in China: A disease-specific quality-of-life questionnaire. Quality of Life Research 16(6):991-996, 2007.
2007 Brod M, Christensen T, BUSHNELL DM. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Quality of Life Research.16(6):1053-1063, 2007.
2007 Brod M, Cobden D, Lammert M, BUSHNELL D, Raskin P. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: Lessons learned from a clinical trial comparing biphasic and basal analogues. Health and Quality of Life Outcomes 5:8, 2007.
2006 Shaw C, Das Gupta R, BUSHNELL DM, Assassa RP, Abrams P, Wagg A, Mayne C, Hardwick C, Martin M. The extent and severity of urinary incontinence amongst women in UK GP waiting rooms. Family Practice 23(5):497-506.
2006 Diehr P, Derleth A, McKenna S, Martin M, BUSHNELL DM, Simon GE, Patrick DL. Synchrony of change in depressive symptoms, health status, and quality of life in persons with clinical depression. Health and Quality of Life Outcomes 4(1):27 (1-10), 2006.
2006 Abraham L, Field B, Svihra J, Hareendran A, Martin ML, BUSHNELL DM, Gong JQ, Levinson I, Streeter J. Electronic diaries: Exploring cross-cultural preferences and acceptability. Drug Information Journal 40(3):259-266, 2006.
2006 BUSHNELL DM, Martin ML, Ricci JF, Bracco A. Performance of the EQ-5D in patients with irritable bowel syndrome. Value in Health 9(2):90-97, 2006.
2006 BUSHNELL DM, Reilly MC, Galani C, Martin ML, Ricci JF, Patrick DL, McBurney CR. Validation of electronic data capture (EDC) of the Irritable Bowel Syndrome-Quality of Life measure (IBS-QOL), the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome (WPAI:IBS) and the EuroQoL (EQ-5D). Value in Health 9(2): 98-105, 2006.
2006 Pickard AS, Dalal MR, BUSHNELL DM. Psychometric evaluation of the Center for Epidemiological Studies – Depression scale in stroke. Value in Health 9(1):59-64, 2006.
2005 BUSHNELL DM, Martin ML, Summers KH, Svihra J, Lionis C, Patrick DL. Quality of Life of Women with Urinary Incontinence: Cross-cultural Performance of 15 Language Versions of the I-QOL. Quality of Life Research 14(8):1901-1913, 2005.
Printed 6/17/2015 Publications Continued
Page 4
2005 Fleck MPdA, Simon G, Herrman H, BUSHNELL D, Martin M, Patrick D, LIDO Group. Major depression and its correlates in primary care settings in six countries: 9-month follow-up study. British Journal of Psychiatry 186:41-47, 2005.
2004 Simon GE, Fleck M, Lucas R, BUSHNELL DM, LIDO Group. Prevalence and predictors of depression treatment in an international primary care study. American Journal of Psychiatry 161:1626-1634, 2004.
2004 Patrick DL, BUSHNELL DM, Rothman M. Performance of two self-report measures for evaluating obesity and weight loss. Obesity Research 12(1):48-57, 2004.
2003 BUSHNELL DM. Contributor to the ISPOR Book of Terms: Health Care Cost, Quality, and Outcomes. Bergner ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW, Dix Smith M (eds.). International Society for Pharmacoeconomics and Outcomes Research: Lawrenceville, NJ, 2003.
2003 Patrick DL, Martin ML, BUSHNELL DM, Pesa J. Measuring satisfaction with migraine treatment: expectations, importance, outcomes and global ratings. Clinical Therapeutics 25(11):2920-2935, 2003.
2003 Bech P, Lucas R, Amir M, BUSHNELL D, Martin M, Buesching D, LIDO Group. Association between clinically depressed subgroups, type of treatment and patient retention in the LIDO study. Psychological Medicine 33:1051-1059, 2003.
2003 BUSHNELL DM, Martin ML, Parasuraman B. Electronic versus paper questionnaires: A further comparison in persons with asthma. Journal of Asthma 40(7):751-762, 2003.
2002 Simon GE, Chisholm D, Knapp M, Treglia M, BUSHNELL DM, LIDO Group. Course of depression, health services costs, and work productivity in an international primary care study. General Hospital Psychiatry 24: 328-335, 2002.
2000 Bonomi AE, Patrick DL, BUSHNELL DM, Martin M. Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. J of Clinical Epidemiology 53:1-12, 2000.
2000 Bonomi AE, Patrick DL, BUSHNELL DM, Martin M. Quality of life measurement: Will we ever be satisfied? J of Clinical Epidemiology 53:19-23, 2000.
1999 Patrick DL, Martin ML, BUSHNELL DM, Marquis P, Andrejasich CM, Buesching DP. Cultural adaptation of a quality-of-life measure for urinary incontinence. European Urology 36:427-435, 1999.
1999 BUSHNELL DM and Martin ML. Quality of life and Parkinson’s disease: Translation and validation of the US Parkinson’s Disease Questionnaire (PDQ-39). Quality of Life Research 8:345-350, 1999.
1999 Patrick DL, Martin ML, BUSHNELL DM, Yalcin I, Wagner TH, Buesching DP. Quality of Life of Women with Urinary Incontinence: Further Development of the Incontinence Quality of Life Instrument (I-QOL). Urology 53:71-76, 1999.
1999 Patrick DL, Martin ML, BUSHNELL DM. The I-QOL: A Quality-of-Life Instrument Specific to Persons with Urinary Incontinence: User’s Manual and Scoring Diskette for United States Version. Seattle, Washington: Health Research Associates, Inc., 1999.
Printed 6/17/2015 Publications Continued
Page 5
1998 Patrick DL, Martin ML, BUSHNELL DM. A Quality-of-Life Measure for Persons with Migraine: User’s Manual and Scoring Diskette for United States Version. Seattle, Washington: Health Research Associates, Inc., 1998.
Published Abstracts 2014 Pierson RF, Traina S, Braam L, BUSHNELL DM, McCarrier KP, Martin ML. The most
frequently reported symptoms of heart failure, their impacts on daily life, and why these matter with respect to clinical outcomes. Quality of Life Research 23(Suppl 1):69, 2014.
2014 Traina S, Pierson RF, Braam L, BUSHNELL DM, McCarrier KP, Martin ML. Concepts most relevant to patients with heart failure to inform clinical decision making. Quality of Life Research 23(Suppl 1):89, 2014.
2013 Wolfe M, Martin ML, Scanlon M, McCarrier KP, BUSHNELL DM. How do patients with different conditions describe their pain? Quality of Life Research 22(Suppl 1):109, 2013.
2013 BUSHNELL DM, Martin ML, Scanlon M, Chau D, Viswanathan HN. A study to examine the equivalence of the paper and electronic versions of the Psoriasis Symptom Inventory (PSI). Value in Health 16(3):A31, 2013.
2013 McCarrier KP, Martin ML, BUSHNELL DM, Abraham L, Bush EN, Houle CR, Mathews M, Carpenter LL, Blum SI, on behalf of the PRO Consortium’s Depression Working Group. Qualitative development and cognitive evaluation of the symptoms of major depressive disorder (S-MDD), a consortium-developed patient reported outcome measure. Value in Health 16(3):A63, 2013.
2013 BUSHNELL DM, McCarrier KP, Scanlon M, Nelson DR, Martin ML, Buesching DP. Validation and psychometric evaluation of a health care orientation assessment. Value in Health 16(3):A34, 2013.
2013 McCarrier KP, BUSHNELL DM, Scanlon M, Nelson DR, Martin ML, Buesching DP. Validation and psychometric evaluation of a patient-reported assessment of disease burden: evidence from a sample of adults with diabetes, depression, and rheumatoid arthritis. Value in Health 16(3):A41, 2013.
2013 McCarrier KP, Martin ML, Ramasamy A, Quintanar-Solares M, BUSHNELL DM, Liedgens H, Blum SI, Argoff CE, Freynhagen R, Wallace MS, Patrick DL. The Pain Assessment for Lower Back Symptoms (PAL-S): Qualitative development and cognitive evaluation of a new patient reported outcome measure for the assessment of low back pain. Value in Health 16(3):A44, 2013.
2013 Ramasamy A, Blum SI, McCarrier KP, Quintanar-Solares M, BUSHNELL DM, Liedgens H, Martin ML, Argoff CE, Patrick DL, Wallace MS, Freynhagen R. The Pain Assessment for Lower Back Impacts (PAL-I): Qualitative development and cognitive evaluation of a new patient reported outcome measure for the assessment of impacts of low back pain. Value in Health 16(3):A4, 2013.
2013 Brod M, Kongsø J, BUSHNELL DM, Rotter JS, Xu Z, Yang L. The impact of memory problems on diabetes treatment in China. Value in Health 16(3):A170, 2013.
Printed 6/17/2015 Published Abstracts - Continued
Page 6
2012 Blum SL, Bush EN, BUSHNELL DM, on behalf of the PRO Consortium’s Depression Working Group. Systematic review of patient-reported outcome measures used to assess symptoms associated with major depressive Disorder. Journal of Mental Health Policy and Economics 15(Suppl 1):S2, Sept. 2012.
2012 BUSHNELL DM, McCarrier K, Martin ML, Paczkowski R, Shen W, Buesching D. Cross-cultural psychometric evaluation of the ENSEMBLE MDS. Value in Health 15(4):A11, 2012.
2012 BUSHNELL DM, McCarrier K, Martin ML, Paczkowski R, Shen W, Buesching D. Paper and web equivalence of the ENSEMBLE MDS – A tool used to collect phenotypic information prior to treatment. Value in Health 15(4):A51, 2012.
2012 BUSHNELL DM, Martin ML, McCarrier K, Chiou CF, Ortmeier B. Comparison of a 24-hour and 7-day version of a patient reported outcome measure for psoriasis symptom severity. Value in Health 15(4):A253, 2012.
2011 McCarrier K, BUSHNELL DM, Martin ML, Paczkowski R, Nelson DR, Buesching D. Validation and psychometric evaluation of a brief combined assessment of depression and anxiety. Value in Health 14(3):A201, 2011.
2011 McCarrier K, BUSHNELL DM, Martin ML, Paczkowski R, Nelson DR, Buesching D. Validation and psychometric evaluation of a 5-item measure of perceived social support. Value in Health 14(3):A148, 2011.
2010 Tulkki-Wilke RK, BUSHNELL DM, Martin ML, Jewett G. Further insight into designing web-based patient reported outcomes for use on personal computers in global studies. Value in Health 13(7):A337, 2010.
2010 Rocha NS, Power MJ, BUSHNELL DM, Fleck MP. EUROHIS-QOL 8: Comparative measurement properties to its parent WHOQOL-BREF measure. Quality of Life Research 19:Suppl 1; 29 (1611), October 2010.
2010 Brod M, Christensen T, Lyager Thomsen T, BUSHNELL D. The impact of non-severe hypoglycemic episodes on work productivity and diabetes management: a four country perspective. Value in Health 13(3):A63-64, 2010.
2010 Brod M, Christensen T, Lyager Thomsen T, BUSHNELL D. The impact of non-severe hypoglycemic episodes on functioning and diabetes management: a 4 country perspective. Value in Health 13(3):A64, 2010.
2009 Brod M, Hammer M, Christensen T, BUSHNELL D. Validation of the Treatment Related Impact Measure for Diabetes Treatment and Device: TRIM-Diabetes and TRIM-Diabetes Device. Value in Health 12(3):A17, 2009.
2009 Brod M, Hammer M, Kragh N, Lessard S, BUSHNELL D. Validation of the Treatment Related Impact Measure for Prescription Weight Loss Medication in Obesity: TRIM-Weight. Value in Health 12(3):A137, 2009.
2008 Hayes RP, BUSHNELL DM, Martin ML. Expectations about and experiences with insulin therapy questionnaires: A preliminary validation study. Quality of Life Research (Suppl, ISOQOL Conference Abstracts Issue):165/1112, A-84, October 2008.
Printed 6/17/2015 Published Abstracts - Continued
Page 7
2008 Rocha NS, Fleck MP, Power MJ, BUSHNELL DM. Rasch analysis of the WHOQOL-BREF in depressed patients from 6 countries worldwide: an example of highlighting existential needs? Quality of Life Research (Suppl, ISOQOL Conference Abstracts Issue):1523, A-7, October 2008.
2007 Christin D, BUSHNELL D. Translation and adaptation errors (TAE): Severity and impact ranking for international studies. Quality of Life Research ISOQOL Conference Abstracts Issue October 2007.
2006 Svihra J, Baska T, Szalayova A, BUSHNELL D, Macko L, Poliak L, Luptak J, Kliment J. The effects of alpha-blockers, finasteride and plant extracts on the need for surgical treatment among Slovakian men with benign prostatic hyperplasia: a cross-sectional study of ten years’ follow-up. Urology 68(Suppl 5A):4, 2006.
2006 Martin M, BUSHNELL DM, Gilbert C, Patrick D, Schünemann H, Hareendran A. Using patient descriptors to develop a PRO measurement strategy for clinical trials: Evaluating the COPD patient’s experience of dyspnea. Value in Health 9(6):A264, 2006.
2006 Brod M, Cobden D, Lammert M, BUSHNELL DM. Myths and realities of treatment satisfaction in diabetes. Value in Health 9(6):A239, 2006.
2005 BUSHNELL DM, Martin ML. Psychometric validation of the UK English incontinence-specific quality of life measure (I-QOL). Value in Health 8(6):A85, 2005.
2005 BUSHNELL DM, Martin ML. Validation of the Symptom Frequency and Bothersomeness scale for stress urinary incontinence (SFB-SUI) in a British population. Value in Health 8(6):A88, 2005.
2005 BUSHNELL DM, Martin ML, Summers KH, Svihra J, Lionis C, Patrick DL. Quality of Life of Women with Urinary Incontinence: Cross-cultural Performance of 15 Language Versions of the I-QOL. Quality of Life Research 14(9):2011, 2005.
2005 Martin ML, Ascoytia CM, BUSHNELL DM. Measuring the effects of combined full spectrum light and negative ions on stress reduction and general well being. Quality of Life Research 14(9):2084, 2005.
2005 Rocha N, Power MJ, Fleck MP, BUSHNELL DM. What are we measuring using WHOQOL-Bref in depressed patients? The LIDO experience. Quality of Life Research 14(9):2016, 2005.
2005 Fleck MP, Rocha N, Power MJ, BUSHNELL DM. WHOQOL-Bref psychometric properties using Rasch analysis – a preliminary study. Quality of Life Research 14(9):2150, 2005.
2005 Gandra SR, BUSHNELL DM, Martin ML, Scanlon PH. Patient reported change in symptoms following laser treatment in diabetic retinopathy. Quality of Life Research 14(9):2046, 2005.
2005 BUSHNELL DM, Galani C, Martin ML, Ricci JF, Reilly M, Patrick DL. Validation of EDC versions of IBS-QOL, EQ-5D, and WPAI:IBS questionnaires. Value in Health 8(3):374, 2005.
2005 Martin ML, Patrick DL, BUSHNELL DM, Gandra SR, Pesa J. Further validation of the Migraine Treatment Satisfaction measure. Value in Health 8(3):318, 2005.
2004 BUSHNELL D, Patrick D, Martin M, Bracco A, Drossman D. Further evaluation of the Irritable Bowel Syndrome – Quality of Life (IBS-QOL) Scale. Gut 53(Suppl VI):A66, 2004.
2004 Pickard AS, Dalal M, BUSHNELL DM. Depression in the general population and after stroke: a psychometric comparison using the CES-D scale. Value in Health 7(3):285, 2004.
Printed 6/17/2015 Published Abstracts - Continued
Page 8
2004 Svihra J, BUSHNELL DM, Martin ML, Sopilko I, Luptak J, Kliment J. Quality of life in stress urinary incontinent patients having surgery with tension free vaginal tape or intravaginal sling. Progrès en Urologie 14(3 Suppl 3):13, 2004.
2003 Martin ML, BUSHNELL DM, Hareendran AV. Psychometric validation of the Benign Prostatic Hyperplasia – Patient Impact Measure (BPH-PIM). Quality of Life Research 12(7):826, 2003.
2003 Martin ML, BUSHNELL DM, Hareendran AV. Psychometric performance of 10 language versions of the Benign Prostatic Hyperplasia – Patient Impact Measure (BPH-PIM). Quality of Life Research 12(7):755, 2003.
2003 BUSHNELL DM, Martin ML, Ricci JF. Performance of the EQ-5D in patients with irritable bowel syndrome. Value in Health 6(6):626-27, 2003.
2003 Martin ML, BUSHNELL DM, Das Gupta RJ, Assassa P, Shaw C. Treatments received for stress urinary incontinence (SUI) symptoms by patients seeking help within a UK primary care setting. Value in Health 6(6):700, 2003.
2003 BUSHNELL DM, Martin ML, Hareendran A, Abraham L. Comparison of the performance and data quality of electronic and paper diaries for benign prostatic hyperplasia (BPH). Value in Health 6(6):704, 2003.
2003 Budhiarso I, Gonzalez-Vizoso R, Martin ML, BUSHNELL DM, Zhang M. The cost-effectiveness of treatment for type I diabetes. Value in Health 6(6):798, 2003.
2003 BUSHNELL DM, Martin ML. Comparing sensitivity to change between I-QOL and SF-36 in a population with urinary incontinence. Value in Health 6(3):289-90, 2003.
2003 Martin ML, BUSHNELL DM, Budhiarso I. Quality of life differences in older adults with varied comorbid conditions. Value in Health 6(3):304-5, 2003.
2003 Martin ML, BUSHNELL DM, Patrick DL. Comparison of weight-related quality of life impacts by age and gender. Value in Health 6(3):324-5, 2003.
2003 BUSHNELL DM, Martin ML, Patrick DL. Comparison of weight-related symptoms and quality of life impacts by body mass index. Value in Health 6(3):325, 2003.
2002 BUSHNELL DM, Patrick DL, Zhang M, Rothman M. The OWLQOL and WRSM in European community studies. Quality of Life Research 11(7):687, 2002.
2002 Martin ML, Goodman JE, BUSHNELL DM, Patrick DL. A more specific meaning for global severity anchors in a population with urinary incontinence. Quality of Life Research 11(7):654, 2002.
2002 Patrick DL, Martin ML, BUSHNELL DM, Mody SH, Fletcher PE. Measuring satisfaction with treatment: Application to migraine headaches. Quality of Life Research 11(7):637, 2002.
2002 Zhang M, Patrick D, BUSHNELL D, Martin S. Employment status and absenteeism associated with obesity and diabetes. Diabetes 51, Suppl 2: June 2002.
2002 Patrick D, BUSHNELL D, Martin S, Zhang M. Quality of life correlates of obesity and diabetes. Diabetes 51, Suppl 2: June 2002.
Printed 6/17/2015 Published Abstracts - Continued
Page 9
2002 Svihra Jan, Baska Tibor, Martin Mona, BUSHNELL Donald, Kliment Jan, Luptak Jan, Sopilko Igor, Dusenka Maria. Prevalence of female overactive bladder with urinary incontinence in Slovakia. European Urology Supplements 1: 85, 2002.
2001 BUSHNELL DM, Martin ML, Parasuraman B. Electronic Versus Paper Questionnaires: A further comparison in People with Asthma. Quality of Life Research 10(3): 2001
2001 Hareendran AV, Martin ML, BUSHNELL DM, Goodman JE. Conceptualization and Design of an Individualized Measure of BPH Impact. Quality of Life Research 10(3): 2001
2001 Martin ML, Hareendran AV, BUSHNELL DM, Goodman JE. Initial Psychometric Performance of an Individualized Measure of PBH Patient Impact (BPH-PIM). Quality of Life Research 10(3): 2001
2001 Patrick DL, BUSHNELL DM, Glauda LA, Gagnon DD, Rothman M. Psychometric evaluation of two obesity and weight-loss quality of life instruments: the OWLQOL and WRSM. Obesity Research 9, Suppl 3:124S, September 2001.
2001 Patrick DL, BUSHNELL DM, Glauda LA, Gagnon DD, Rothman M. Quality of life of enrollees and non-enrollees in formal weight-loss programs. Obesity Research 9, Suppl 3:125S, September 2001.
2000 BUSHNELL DM, Amir M. Evaluation of the WHOQOL-Bref in Six Countries: A Cross-Cultural Evaluation Using Rasch Item Response Theory. Quality of Life Research 9(3):269, 2000.
2000 BUSHNELL DM, Patrick DL, Martin ML, Kody MC, Buesching DP, Breier A. The Quality of Life Scale (QLS) for Schizophrenia: Assessment of Responsiveness to Clinical Change. Quality of Life Research 9(3):336, 2000.
1999 Martin ML, BUSHNELL DM, Gore M. A tool for subject assessment of incontinence symptoms and episodes. Quality of Life Research 8(7):646, November 1999.
1999 Bonomi AE, Patrick DL, BUSHNELL DM, Martin D. Quality of life of mothers and their partner (spouse) following the birth of a child. Quality of Life Research 8(7):558 November, 1999.
1999 ter Smitten M, Simon G, BUSHNELL D, van den Brink W. Tailoring to fit: CIDI-depression in the LIDO study. Quality of Life Research 8(7):613, November 1999.
1999 Lucas R, BUSHNELL D. Quality of life and depression among primary care patients in Barcelona, Spain. Quality of Life Research 8(7):646, November 1999.
1999 Budhiarso I, BUSHNELL DM. Price elasticity of people’s willingness to pay in patients with urinary incontinence. Value in Health 2(3):139, May/June 1999.
1999 Budhiarso I, BUSHNELL D, Ramsey S. Willingness to pay of patients with painful-irritable bladder syndrome. Value in Health 2(1):27, January/February 1999.
1998 BUSHNELL D, Budhiarso I, Martin ML, Patrick DL. Psychometric properties of a QoL measure for painful-irritable bladder syndrome. Quality of Life Research 7(7):577-578 November 1998.
Printed 6/17/2015 Published Abstracts - Continued
Page 10
1998 Budhiarso I, BUSHNELL D, Martin M, T Hogan. Impact of patient diary format on quality of life outcomes in people with Parkinson’s disease. Quality of Life Research 7(7):576-577 November 1998.
1997 Patrick DL, Bonomi AE, BUSHNELL DM, Goodman J, Martin M, Wild D. US WHOQOL instruments in development and application. Quality of Life Research 6:696, 1997.
1997 Patrick DL, Martin M, BUSHNELL D, Marquis P, Andrejasich C, Buesching D. Cultural adaptation of a quality-of-life measure for urinary incontinence (I-QOL). Neurology and Urodynamics 16(5):462-463, 1997.
1997 BUSHNELL D, Martin ML, Grippi J. The translation and validation of a quality of life instrument for Parkinson’s disease. Drug Information Journal 31(4):1412-1413, 1997.
1997 Ramsey SD, Martin ML, BUSHNELL D, Goodman J. Willingness to pay for treatment of urinary incontinence: A psychometric approach to instrument development. Drug Information Journal 31(4):1429, 1997.
Revised 6/17/2015 Manuscripts in Preparation
Page 11
Manuscripts in Preparation McCarrier KP, BUSHNELL DM, Martin ML, Paczkowski R, Buesching D. Development and
Validation of a Patient-Reported Questionnaire Battery to Characterize the Baseline Heterogeneity of Clinical Trial Participants.
Gwaltney CJ, Slagle AF, BUSHNELL DM, Meyers O, Brede Y, Ariely R. Psychometric Evaluation of the Clinical Summary Score from the Kansas City Cardiomyopathy Questionnaire.
Hareendran A, BUSHNELL DM, Martin ML. The development and validation of a patient reported outcome measure to evaluate treatments for urinary symptoms of BPH (Benign Prostatic Hyperplasia). Proposed to submit to Urology.
BUSHNELL DM, Patrick DL, Martin ML, Kody MC, Buesching DP, Breier A. The quality of life scale (QLS) for schizophrenia: Assessment of responsiveness to clinical change. Proposed to submit to Quality of Life Research.
BUSHNELL DM, Patrick DL, Martin ML, Ricci JF, Drossman DA. Cross-cultural evaluation of the Irritable Bowel Syndrome-Quality of Life Scale (IBS-QOL). Proposed to submit to Quality of Life Research.
Conference Presentations
* 2015 BUSHNELL DM, Geister TL, Budhiarso I, Liu Z, Jie Y, Zhang Y, Martin ML. Psychometric validation of the questionnaire on pain caused by Spasticity (QPS). 22nd Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, BC, Canada, October 23, 2015. [2052]
* 2015 BUSHNELL DM, McCarrier KP, Ramasamy A, Liedgens H, Braam L, Martin ML, Blum SI. Preliminary measurement properties of the Pain Assessment for Lower Back-Impacts questionnaire (PAL-I): Development using a mixed methods approach. 22nd Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, BC, Canada, October 23, 2015. [3043]
2015 McCarrier KP, BUSHNELL DM, Ramasamy A, Liedgens H, Braam L, Martin ML, Blum SI. Preliminary measurement properties of the Pain Assessment for Lower Back-Symptoms (PAL-S): Development and evaluation through a mixed-methods approach. 22nd Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, BC, Canada, October 23, 2015. [3045]
2015 Braam L, Pierson RF, BUSHNELL DM, Martin ML. Systematic review of patient-reported outcome measures used to assess symptoms associated with heart failure. 22nd Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, BC, Canada, October 22, 2015. [1011]
2015 Stassek L, BUSHNELL DM, McCarrier KP, Supina D. Patient Experience with Hereditary Angioedema (HAE): A Review of the Literature. 22nd Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, BC, Canada, October 22, 2015. [1021]
Revised 6/17/2015 Conference Presentations
Page 12
* Primary Presenter
2015 Feldman S, BUSHNELL DM, Klekotka P, Martin ML, Wade SW, Scanlon M, Yang W, Pinto L, Kircik L, Viswanathan HN. Differences between patient and physician global assessments of psoriasis symptoms in patients on biologic therapy. 12th European Academy of Dermatology and Venereology (EADV) Spring Symposium, Valencia, Spain, March 5-8, 2015.
2015 Feldman S, BUSHNELL D, Viswanathan HN, Martin M, Wade SW, Scanlon M, Yang W, Pinto L, Kircik L, Klekotka P. Differences in Patient Reported Psoriasis Symptom Severity between Patients Rated as ‘Clear’ Versus ‘Almost Clear’ based on Physician Global Assessment. 73rd Annual Meeting of the American Academy of Dermatology (AAD), San Francisco, CA, March 20-24, 2015.
* 2014 BUSHNELL DM, McCarrier KP, Ramasamy A, Liedgens H, Blum SI, Cano SJ, Martin ML, Patrick DL. Impacts of low back pain: refinement of the Pain Assessment for Lower Back-Impacts questionnaire (PAL-I) using a mixed methods approach. 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Amsterdam, The Netherlands, November 8-12, 2014. [PSY83]
* 2014 McCarrier KP, BUSHNELL DM, Ramasamy A, Liedgens H, Blum SI, Cano SJ, Martin ML, Patrick DL. The Pain Assessment for Lower Back Symptoms (PAL-S): Refinement of a new PRO instrument through a mixed methods approach. 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Amsterdam, The Netherlands, November 8-12, 2014. [PSY82]
2014 BUSHNELL DM, Feldman S, Viswanathan HN, Martin ML, Wade SW, Scanlon M, Yang W, Pinto L, Kircik L, Klekotka P. Differences in patient reported psoriasis health-related quality of life between patients rated as ‘clear’ versus ‘almost clear’ based on physician global assessment. Skin Disease Education Foundation's (SDEF) 15th Annual Las Vegas Dermatology Seminar, Las Vegas, NV, October 30-November 1, 2014.
2014 Pierson RF, Traina S, Braam L, BUSHNELL DM, McCarrier KP, Martin ML. The most frequently reported symptoms of heart failure, their impacts on daily life, and why these matter with respect to clinical outcomes. 21th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Berlin, Germany, October 16, 2014. [1017]
* 2014 Traina S, Pierson RF, Braam L, BUSHNELL DM, McCarrier KP, Martin ML. Concepts most relevant to patients with heart failure to inform clinical decision making. 21th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Berlin, Germany, October 16, 2014. [1022]
2013 Brod M, Ramasamy A, BUSHNELL DM, Blum SI. The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric validation of a new patient reported outcome. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual European Congress, Dublin, November 2-6, 2013. [PDB87]
* 2013 Award finalist
BUSHNELL DM, Martin ML, Scanlon M, Chau D, Viswanathan HN. A study to examine the equivalence of the paper and electronic versions of the Psoriasis Symptom Inventory (PSI). 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [PRM103]
Revised 6/17/2015 Conference Presentations
Page 13
* Primary Presenter
2013 McCarrier KP, Martin ML, BUSHNELL DM, Abraham L, Bush EN, Houle CR, Mathews M, Carpenter LL, Blum SI, on behalf of the PRO Consortium’s Depression Working Group. Qualitative development and cognitive evaluation of the symptoms of major depressive disorder (S-MDD), a consortium-developed patient reported outcome measure. 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [PMH46]
* 2013 BUSHNELL DM, McCarrier KP, Scanlon M, Nelson DR, Martin ML, Buesching DP. Validation and psychometric evaluation of a health care orientation assessment. 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [PRM119]
2013 McCarrier KP, BUSHNELL DM, Scanlon M, Nelson DR, Martin ML, Buesching DP. Validation and psychometric evaluation of a patient-reported assessment of disease burden: evidence from a sample of adults with diabetes, depression, and rheumatoid arthritis. 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [PRM157]
2013 McCarrier KP, Martin ML, Ramasamy A, Quintanar-Solares M, BUSHNELL DM, Liedgens H, Blum SI, Argoff CE, Freynhagen R, Wallace MS, Patrick DL. The Pain Assessment for Lower Back Symptoms (PAL-S): Qualitative development and cognitive evaluation of a new patient reported outcome measure for the assessment of low back pain. 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [PRM173]
2013 Ramasamy A, Blum SI, McCarrier KP, Quintanar-Solares M, BUSHNELL DM, Liedgens H, Martin ML, Argoff CE, Patrick DL, Wallace MS, Freynhagen R. The Pain Assessment for Lower Back Impacts (PAL-I): Qualitative development and cognitive evaluation of a new patient reported outcome measure for the assessment of impacts of low back pain. 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [P03]
2013 Brod M, Kongsø J, BUSHNELL DM, Rotter JS, Xu Z, Yang L. The impact of memory problems on diabetes treatment in China. 18th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), New Orleans, LA, USA, May 18-22, 2013. [PDB78]
2012 Scanlon M, Martin ML, McCarrier K, Wolfe M, BUSHNELL DM. Mapping the meanings of words patients use to describe their pain. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual European Congress, Berlin, Germany, November 6, 2012.
2012 Blum SI, Bush EN, BUSHNELL DM. Systematic review of patient-reported outcome measures used to assess symptoms associated with major depressive disorder. International Center of Mental Health Policy and Economics, First Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health, Washington, DC, USA, September 30, 2012.
* 2012 McCarrier K, BUSHNELL DM, Martin ML, Paczkowski R, Buesching D. Validation and psychometric evaluation of a truncated version of the Total Illness Burden Index. AcademyHealth’s 2012 Annual Research Meeting (ARM), Orlando, Florida, USA, June 25, 2012.
Revised 6/17/2015 Conference Presentations
Page 14
* Primary Presenter
* 2012 BUSHNELL DM, McCarrier K, Martin ML, Chiou CF, Ortmeier B. Comparison of a 24-hour and 7-day version of a patient reported outcome measure for psoriasis symptom severity. 17th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, DC, USA, June 6, 2012
* 2012 Award finalist
BUSHNELL DM, McCarrier K, Martin ML, Paczkowski R, Shen W, Buesching D. Paper and web equivalence of the ENSEMBLE MDS - a tool used to collect phenotypic information prior to treatment. 17th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, DC, USA, June 4, 2012.
* 2012 BUSHNELL DM, McCarrier K, Martin ML, Paczkowski R, Shen W, Buesching D. Cross-cultural psychometric evaluation of the ENSEMBLE MDS. 17th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, DC, USA, June 5, 2012.
2011 McCarrier K, BUSHNELL DM, Martin ML, Paczkowski R, Nelson DR, Buesching D. Validation and psychometric evaluation of a 5-item measure of perceived social support. 16th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, Maryland, USA, May, 2011.
2011 McCarrier K, BUSHNELL DM, Martin ML, Paczkowski R, Nelson DR, Buesching D. Validation and psychometric evaluation of a brief combined assessment of depression and anxiety. 16th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Baltimore, Maryland, USA, May, 2011.
2010 Rocha NS, Power MJ, BUSHNELL DM, Fleck MP. The EUROHIS-QOL 8: Comparative measurement properties to its parent WHOQOL-BREF measure. 17th Annual Conference of the International Society for Quality of Life Research (ISOQOL), London, England, October, 2010.
2010 Tulkki-Wilke RK, BUSHNELL DM, Martin ML, Jewett G. Further insight into designing web-based patient reported outcomes for use on personal computers in global studies. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual European Congress, Prague, Czech Republic, November, 2010.
2009
Brod M, Christensen T, Thomsen TL, BUSHNELL D. The impact of diabetic non-severe hypoglycemic episodes on functioning and diabetes management: a 4 country perspective. 15th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, Georgia, USA, May 17, 2010.
2009
Brod M, Christensen T, Thomsen TL, BUSHNELL D. The impact of non-severe hypoglycemic episodes on work productivity and diabetes management: a 4 country perspective. 15th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Atlanta, Georgia, USA, May 17, 2010.
2009
Brod M, Christensen T, Thomsen TL, BUSHNELL D. The cost of diabetes related minor hypoglycemic events in working adults. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 12th Annual European Congress, Paris, France, October 27, 2009.
2009 Best Podium
Research Award
Brod M, Hammer M, Christensen T, BUSHNELL D. Validation of the Treatment Related Impact Measure for Diabetes Treatment and Device: TRIM-Diabetes and TRIM-Diabetes Device. 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Orlando, Florida, USA, May 18, 2009.
Revised 6/17/2015 Conference Presentations
Page 15
* Primary Presenter
2009 Brod M, Hammer M, Kragh N, Lessard S, BUSHNELL D. Validation of the Treatment Related Impact Measure for Prescription Weight Loss Medication in Obesity: TRIM-Weight. 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Orlando, Florida, USA, May 18, 2009.
2008 Hayes RP, BUSHNELL DM, Martin ML. Expectations about and experiences with insulin therapy questionnaires: A preliminary validation study. 15th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Montevideo, Uruguay, October 24, 2008.
2008 Award
Rocha NS, Fleck MP, Power MJ, BUSHNELL DM. Rasch analysis of the WHOQOL-BREF in depressed patients from 6 countries worldwide: an example of highlighting existential needs? 15th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Montevideo, Uruguay, October 23, 2008.
2008 BUSHNELL DM, Gilbert C, Martin ML, Hareendran A, Patrick DL, Schünemann HJ. Using the Dyspnea Profile Diary (DPD) to capture individual variation in the experience of symptoms of dyspnea reported by patients with Chronic Obstructive Pulmonary Disease (COPD). International Conference of the American Thoracic Society (ATS), Toronto, Canada, May 2008.
2008 Martin ML, BUSHNELL DM, Parasuraman B , Meltzer EO, Patrick DL. Validation of the Asthma Treatment Satisfaction Measure (ATSM). International Conference of the American Thoracic Society (ATS), Toronto, Canada, May 2008.
2008 Martin ML, BUSHNELL DM, Parasuraman B , Meltzer EO, Patrick DL. Increasing sensitivity of the Asthma Treatment Satisfaction Measure (ATSM) by Incorporating Patient Expectations and Importance of Treatment Attributes Into Satisfaction Ratings. International Conference of the American Thoracic Society (ATS), Toronto, Canada, May 2008.
2008 Patrick DL, Martin ML, BUSHNELL DM, Meltzer EO, Parasuraman B. Development of a treatment satisfaction measure for patients with asthma: The Asthma Treatment Satisfaction Measure (ATSM). International Conference of the American Thoracic Society (ATS), Toronto, Canada, May 2008.
2007 Abraham L, Symonds T, DeRogatis LR, Patrick DL, Martin ML, BUSHNELL DM. Further evidence of the Sexual Function Questionnaire as a screening tool for women with sexual dysfunction. Sexual Medicine Society of North America 2007 Fall Meeting, Chicago, Illinois, USA, December 6-9, 2007.
2007 Hareendran A, Martin ML, BUSHNELL DM, Gilbert C, Schünemann HJ, Patrick DL. Cross-cultural patient endorsement of distinct sensations of dyspnea in Chronic Obstructive Pulmonary Disease (COPD): implications for measurement. International Conference of the American Thoracic Society (ATS), San Francisco, California, USA, May 18-23, 2007.
2007 Gilbert C, Martin ML, Hareendran A, BUSHNELL DM, Patrick DL, Schünemann HJ. Capturing individual variation in the experience of symptoms reported by patients with Chronic Obstructive Pulmonary Disease (COPD). International Conference of the American Thoracic Society (ATS), San Francisco, California, USA, May 18-23, 2007.
Revised 6/17/2015 Conference Presentations
Page 16
* Primary Presenter
2006 Svihra J, Baska T, Szalayova A, BUSHNELL D, Macko L, Poliak L, Luptak J, Kliment J. The effects of alphablockers, finasteride and plant extracts on the need for surgical treatment among Slovakian men with benign prostatic hyperplasia – a cross-sectional study of ten-year follow–up. 28th Congress of the Société Internationale d’Urologie, Cape Town, South Africa, November 12-16, 2006.
2006 Martin M, BUSHNELL DM, Gilbert C, Patrick D, Schünemann H, Hareendran A. Using patient descriptors to develop a PRO measurement strategy for clinical trials: Evaluating the COPD patient’s experience of dyspnea. 9th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Copenhagen, Denmark, October 29, 2006.
2006 Award finalist
Brod M, Cobden D, Lammert M, BUSHNELL DM. Myths and realities of treatment satisfaction in diabetes. 9th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Copenhagen, Denmark, October 29, 2006.
2006 Huang W, Zhou F, BUSHNELL DM, Diakite C, Yang X. Cultural adaptation and application of the IBS-QOL in China: A disease-specific quality-of-life questionnaire. Hong Kong Society of Quality of Life (HKSoQOL), Hong Kong, May 19-21, 2006.
2006 Huang W, Zhou F, BUSHNELL DM, Diakite C, Yang X. Comparison of the Effects of Different Medical Therapies to Patients With Irritable Bowel Syndrome and Related Research on Quality of Life. Hong Kong Society of Quality of Life (HKSoQOL), Hong Kong, May 19-21, 2006.
2006 Abraham L, Althof SE, BUSHNELL DM, Martin ML, May K, Symonds T. Psychometric Validation of a Sexual Satisfaction Measure for Female Partners of Men With Premature Ejaculation (PE): PE Partner Satisfaction Index (PEP-SI). Annual Meeting of the International Society for the Study of Women's Sexual Health (ISSWSH), Lisbon, Portugal, March 9-12, 2006.
*2005 BUSHNELL DM, Martin ML. Psychometric validation of the UK English incontinence-specific quality of life measure (I-QOL). 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Florence, Italy, November 6, 2005.
2005 BUSHNELL DM, Martin ML. Validation of the Symptom Frequency and Bothersomeness scale for stress urinary incontinence (SFB-SUI) in a British population. 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Florence, Italy, November 6, 2005.
*2005 BUSHNELL DM, Martin ML, Summers KH, Svihra J, Lionis C, Patrick DL. Quality of Life of Women with Urinary Incontinence: Cross-cultural Performance of 15 Language Versions of the I-QOL. 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL), San Francisco, California, USA, October 21, 2005.
2005 Rocha N, Power MJ, Fleck MP, BUSHNELL DM. What are we measuring using WHOQOL-Bref in depressed patients? The LIDO experience. 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL), San Francisco, California, USA, October 22, 2005.
2005 Fleck MP, Rocha N, Power MJ, BUSHNELL DM. WHOQOL-Bref psychometric properties using Rasch analysis – a preliminary study. 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL), San Francisco, California, USA, October 22, 2005.
Revised 6/17/2015 Conference Presentations
Page 17
* Primary Presenter
2005 Gandra SR, BUSHNELL DM, Martin ML, Scanlon PH. Patient reported change in symptoms following laser treatment in diabetic retinopathy. 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL), San Francisco, California, USA, October 19, 2005.
2005 Martin ML, Ascoytia CM, BUSHNELL DM. Measuring the effects of combined full spectrum light and negative ions on stress reduction and general well being. 12th Annual Conference of the International Society for Quality of Life Research (ISOQOL), San Francisco, California, USA, October 22, 2005.
2005 Svihra J, Baska T, Szalayova A, BUSHNELL D, Macko L, Poliak L, Luptak J, Kliment J. The effects of alphablockers, finasteride and plant extracts on the need for surgical treatment among Slovakian men with benign prostatic hyperplasia – a cross-sectional study of ten-year follow–up. 6th International Consultation on New Developments in Prostate Cancer and Prostate Disease, Paris, France, June 24-27, 2005.
2005 Patrick DL, Barghout V, Pecher E, BUSHNELL DM, McBurney CR. Tegaserod significantly improves health-related quality of life and patient satisfaction in patients with IBS-C. Digestive Disease Week 2005 (DDW), Chicago, Ill., USA, May 14-19, 2005.
2005 BUSHNELL DM, Galani C, Martin ML, Ricci JF, Reilly M, Patrick DL. Validation of EDC versions of IBS-QOL, EQ-5D, and WPAI:IBS questionnaires. 10th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, DC, USA, May 15-18, 2005.
2005 Martin ML, Patrick DL, BUSHNELL DM, Gandra SR, Pesa J. Further validation of the Migraine Treatment Satisfaction measure. 10th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington, DC, USA, May 15-18, 2005.
*2004 BUSHNELL D, Martin M, Ting BL. Seminars on the Theories and Practice of Outcomes Research. Taiwan Society for Pharmacoeconomics and Outcomes Research (TASPOR), Taipei, Taiwan, October 19, 2004.
2004 Martin M, Derleth A, BUSHNELL D. Evaluating Depressive Symptoms in Primary Care Populations: The LIDO Study. 11th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Hong Kong, October 18, 2004.
*2004 BUSHNELL D, Martin M. A New Conceptual Model for the Assessment of Patient Satisfaction with Treatment. Third National Quality of Life Symposium, Guangzhou, People’s Republic of China, October 12, 2004.
*2004 BUSHNELL D, Patrick D, Martin M, Bracco A, Drossman D. Further evaluation of the Irritable Bowel Syndrome – Quality of Life (IBS-QOL) Scale. 12th United European Gastroenterology Week (UEGW), Prague, Czech Republic, September 29, 2004.
2004 Bech P, Lucas R, BUSHNELL D, Martin M. Quality of life among different clinically depressed subgroups (The LIDO study). 10th International Congress of the International Federation of Psychiatric Epidemiology (IFPE), Bristol and Bath, UK, September 10-13, 2004.
2004 Svihra J, BUSHNELL DM, Martin ML, Sopilko I, Luptak J, Kliment J. Quality of life in stress urinary incontinent patients having surgery with tension free vaginal tape or intravaginal sling. 3rd International Consultation on Incontinence (ICI), Monaco, June 26-29, 2004.
Revised 6/17/2015 Conference Presentations
Page 18
* Primary Presenter
2004 Pickard AS, Dalal M, BUSHNELL DM. Depression in the general population and after stroke: a psychometric comparison using the CES-D scale. 9th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, Virginia, USA, May 17, 2004.
2004 Wagg AS, BUSHNELL D, Das Gupta RJ. Treatments received for stress urinary incontinence (SUI) symptoms by patients referred to secondary care within a UK setting. 11th Annual Scientific Meeting of the International Continence Society (ICS) United Kingdom, Bournemouth, UK, March 19, 2004.
2003 Martin ML, BUSHNELL DM, Hareendran AV. Psychometric validation of the Benign Prostatic Hyperplasia – Patient Impact Measure (BPH-PIM). 10th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Prague, Czech Republic, November 14, 2003.
2003 Martin ML, BUSHNELL DM, Hareendran AV. Psychometric performance of 10 language versions of the Benign Prostatic Hyperplasia – Patient Impact Measure (BPH-PIM). 10th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Prague, Czech Republic, November 14, 2003.
*2003 BUSHNELL DM, Martin ML, Ricci JF. Performance of the EQ-5D in patients with irritable bowel syndrome. 6th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Barcelona, Spain, November 11, 2003.
*2003 Award
BUSHNELL DM, Martin ML, Hareendran A, Abraham L. Comparison of the performance and data quality of electronic and paper diaries for benign prostatic hyperplasia (BPH). 6th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Barcelona, Spain, November 9-10, 2003.
2003 Martin ML, BUSHNELL DM, Das Gupta RJ, Assassa P, Shaw C. Treatments received for stress urinary incontinence (SUI) symptoms by patients seeking help within a UK primary care setting. 6th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Barcelona, Spain, November 9-10, 2003.
2003 Budhiarso I, Gonzalez-Vizoso R, Martin ML, BUSHNELL DM, Zhang M. The cost-effectiveness of treatment for type I diabetes. 6th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Barcelona, Spain, November 10, 2003.
2003 Patrick DL, Martin ML, BUSHNELL DM, Pesa J. Measuring satisfaction with treatment: Application to migraine headaches. 45th Annual Scientific Meeting of the American Headache Society (AHS), Chicago, Illinois, USA, June 19-22, 2003.
*2003 BUSHNELL DM, Martin ML. Comparing sensitivity to change between I-QOL and SF-36 in a population with urinary incontinence. 8th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, Virginia, USA, November 19, 2003.
2003 Martin ML, BUSHNELL DM, Budhiarso I. Quality of life differences in older adults with varied comorbid conditions. 8th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, Virginia, USA, November 20, 2003.
Revised 6/17/2015 Conference Presentations
Page 19
* Primary Presenter
2003 Award finalist
Martin ML, BUSHNELL DM, Patrick DL. Comparison of weight-related quality of life impacts by age and gender. 8th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, Virginia, USA, November 20, 2003.
*2003 BUSHNELL DM, Martin ML, Patrick DL. Comparison of weight-related symptoms and quality of life impacts by body mass index. 8th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Arlington, Virginia, USA, November 20, 2003.
2003 Robinson RL, BUSHNELL DM. Impact of pain on depression in international primary care. American Psychosomatic Society (APS), Phoenix, Arizona, USA, March 5-8, 2003.
*2003 BUSHNELL DM. How to distinguish good from bad QOL measures in reading reports of psychometric properties? Quality of Life Symposium, 2003. Hospital Authority, Hong Kong, January 12, 2003.
*2002 BUSHNELL DM, Patrick DL, Zhang M, Rothman M. The OWLQOL and WRSM in European community studies. 9th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Orlando, Florida, USA, November 1, 2002.
2002 Martin ML, Goodman JE, BUSHNELL DM, Patrick DL. A more specific meaning for global severity anchors in a population with urinary incontinence. 9th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Orlando, Florida, USA, November 1, 2002.
2002 Patrick DL, Martin ML, BUSHNELL DM, Mody SH, Fletcher PE. Measuring satisfaction with treatment: Application to migraine headaches. 9th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Orlando, Florida, USA, November 1, 2002.
2002 Robinson RL, BUSHNELL DM. Impact of pain on depression in international primary care for LIDO. World Psychiatric Association (WPA), Yokohama, Japan, August 28, 2002.
2002 Svihra J, Baska T, Martin ML, BUSHNELL DM, Kliment J, Luptak J, Sopilko I, Dusenka M. Prevalence of female overactive bladder with urinary incontinence in Slovakia. Congress of The European Association of Urology (EAU), Birmingham, England, February 23-26, 2002.
*2001 BUSHNELL DM, Martin ML. Depression and quality of life and their effect on health care utilization. 4th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Cannes, France, November 11-13, 2001.
2001 Patrick DL, BUSHNELL DM, Glauda LA, Gagnon DD, Rothman M. Psychometric evaluation of two obesity and weight-loss quality of life instruments: the OWLQOL and WRSM. 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Amsterdam, The Netherlands, November 7-10, 2001.
2001 Patrick DL, BUSHNELL DM, Glauda LA, Gagnon DD, Rothman M. Quality of life of enrollees and non-enrollees in formal weight-loss programs. 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Amsterdam, The Netherlands, November 7-10, 2001.
Revised 6/17/2015 Conference Presentations
Page 20
* Primary Presenter
2001 Hareendran AV, Martin ML, BUSHNELL DM, Goodman JE. Conceptualization and design of an individualized measure of BPH (Benign Prostatic Hyperplasia) impact. 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Amsterdam, The Netherlands, November 7-10, 2001.
2001 Martin ML, Hareendran AV, BUSHNELL DM, Goodman JE. Initial psychometric performance of an individualized measure of BPH patient impact BPH-PIM. 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Amsterdam, The Netherlands, November 7-10, 2001.
*2001 BUSHNELL DM, Martin ML, Parasuraman B. Electronic versus paper questionnaires: A further comparison in persons with asthma. 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Amsterdam, The Netherlands, November 7-10, 2001.
*2001 BUSHNELL DM, Martin ML, Svihra J. Evaluating the performance of a new Slovak version of the Incontinence-specific Quality of Life measure (I-QOL). 8th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Amsterdam, The Netherlands, November 7-10, 2001.
*2001 Patrick DL, BUSHNELL DM, Glauda LA, Gagnon DD, Rothman M. Psychometric evaluation of two obesity and weight-loss quality of life instruments: the OWLQOL and WRSM. The North American Association for the Study of Obesity (NAASO) Annual Scientific Meeting, Québec City, Canada, October 7-10, 2001.
*2001 Patrick DL, BUSHNELL DM, Glauda LA, Gagnon DD, Rothman M. Quality of life of enrollees and non-enrollees in formal weight-loss programs. The North American Association for the Study of Obesity (NAASO) Annual Scientific Meeting, Québec City, Canada, October 7-10, 2001.
2001 Svihra J, Baska T, Martin ML, BUSHNELL DM, Lachvac L, Valansky L, Luptak J, Sopilko I, Dusenka M. Epidemiology of female urinary incontinence in Slovakia. 2nd International Consultation on Incontinence, Paris, France, July 1-3, 2001.
*2000 BUSHNELL DM, Whalley D. Evaluation of the CES-D in Six Countries Using Rasch Item Response Theory (IRT) Analysis. 3rd Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Antwerp, Belgium, November 6, 2000.
*2000
BUSHNELL DM, Amir M. Evaluation of the WHOQOL-Bref in Six Countries: A Cross-Cultural Evaluation Using Rasch Item Response Theory. 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, B.C., Canada, October 29-30, 2000.
*2000 BUSHNELL DM, Patrick DL, Martin ML, Kody MC, Buesching DP, Breier A. The Quality of Life Scale (QLS) for Schizophrenia: Assessment of Responsiveness to Clinical Change. 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, B.C., Canada, October 29-30, 2000.
2000 Lomachenkov A, BUSHNELL DM. Unrecognized Depression in Medical Health Care and Resource Utilization. XIIIth Congress of the Russian Psychiatric Association, Moscow, Russia, October 10-13, 2000.
Revised 6/17/2015 Conference Presentations
Page 21
* Primary Presenter
2000 Lomachenkov A, Kabanov M, BUSHNELL DM. Quality of Life of Patients with Unrecognized Depression in Medical Health Care. All-Russian Scientific Conference with International Participation “Quality of Life Investigations in Medicine,” June 4-5, 2000.
2000 Lomachenkov A, Kabanov M, BUSHNELL DM. Depression in Primary Health Care in St. Petersburg. VII World Congress-World Psychiatric Association, Paris, France, May 7-10, 2000.
1999 Martin ML, BUSHNELL DM, Gore M. A Tool for Subject Assessment of Incontinence Symptoms and Episodes. 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Barcelona, Spain, November 3-6, 1999.
1999 Lucas R, BUSHNELL D. Quality of Life and Depression among Primary Care Patients in Barcelona, Spain. 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Barcelona, Spain, November 3-6, 1999.
1999 Bonomi AE, Patrick DL, BUSHNELL DM, Martin DT. Quality of Life of Mothers and their Partner (Spouse) Following the Birth of a Child. 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Barcelona, Spain, November 3-6, 1999.
1999 ter Smitten M, Simon G, BUSHNELL D, van den Brink W. Tailoring to fit: CIDI-Depression in the LIDO Study. 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Barcelona, Spain, November 3-6, 1999.
1999 Budhiarso I, BUSHNELL DM. Price Elasticity of People's Willingness To Pay in Patients with Urinary Incontinence. Fourth Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Crystal City, VA (Washington DC), May 23-26, 1999.
*1999 BUSHNELL DM, Martin ML, Patrick DL, Andrejasich C, Gore M. Development of an “Individually-Defined” Activities Limitation Scale. Sixth Annual Symposium of Contributed Papers on Quality of Life Evaluation – Drug Information Association (DIA), Hilton Head, South Carolina, March 28-30, 1999.
*1998 Budhiarso I, BUSHNELL DM, Ramsey SD. Willingness to Pay of Patients with Painful-Irritable Bladder Syndrome (PIBS). Inaugural European Conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Köln, Germany, December 10-12, 1998.
*1998 BUSHNELL DM, Budhiarso I, Martin ML, Patrick DL, Andrejasich C. Psychometric Properties of a QOL Measure for Painful-Irritable Bladder Syndromes (PIBS). Fifth Annual Conference of the International Society for Quality of Life Research (ISOQOL), Baltimore, Maryland, November 15-17, 1998.
1998 Budhiarso I, BUSHNELL DM, Martin ML, Hogan T. Impact of Patient Diary Format on Quality of Life Outcomes in People with Parkinson’s Disease. Fifth Annual Conference of the International Society for Quality of Life Research (ISOQOL), Baltimore, Maryland, November 15-17, 1998.
1998 Ramsey SD, Budhiarso I, Martin ML, BUSHNELL DM, Patrick DL. Willingness to Pay in Patients with Urinary Incontinence. Fifth Annual Conference of the International Society for Quality of Life Research (ISOQOL), Baltimore, Maryland, November 15-17, 1998.
Revised 6/17/2015 Conference Presentations
Page 22
* Primary Presenter
1998 Patrick DL, Martin ML, BUSHNELL DM, Yalcin I, Wagner TH, Buesching DP. Clinical and Quality of Life Impacts of Urinary Incontinence in Women. 28th Annual Meeting of the International Continence Society, Jerusalem, Israel, September 14-17, 1998.
1997 Patrick DL, Bonomi AE, BUSHNELL DM, Goodman JE, Martin ML, Wild D. U.S. WHOQOL Instruments in Development and Application. Fourth Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vienna, Austria, November 5-9, 1998.
1997 Patrick DL, Martin ML, BUSHNELL DM, Marquis P, Andrejasich C, Buesching DP. Cultural Adaptation of a Quality of Life Measure for Urinary Incontinence (I-QOL). 27th Annual Meeting of the International Continence Society, Yokohama, Japan, September 23-26, 1997.
1997 Martin ML, BUSHNELL DM, Grippi J. Translation and Validation of a Quality of Life Instrument for Parkinson’s Disease. Fourth Annual Symposium of Contributed Papers on Quality of Life Evaluation - Drug Information Association (DIA), Charleston, South Carolina, May 12-13, 1997.
1997 Ramsey SD, Martin ML, BUSHNELL DM, Goodman JE, Patrick DL. Willingness to Pay for Treatment of Urinary Incontinence: A Psychometric Approach to Instrument Development. Fourth Annual Symposium of Contributed Papers on Quality of Life Evaluation - Drug Information Association (DIA), Charleston, South Carolina, May 12-13, 1997.
1993 Patrick DL, BUSHNELL DM, Martin ML, Goodman JE, Preston SD. Measuring Health-Related Quality of Life (HrQol). Eighth National Conference on Chronic Disease Prevention and Control, Kansas City, Missouri, November 17-19, 1993.
Revised 6/17/2015
Page 23
Professional Organizations International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
International Society of Quality of Life Research (ISOQOL)
